156 related articles for article (PubMed ID: 2992966)
1. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
3. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
[TBL] [Abstract][Full Text] [Related]
4. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
[TBL] [Abstract][Full Text] [Related]
5. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.
Wood CL; O'Dorisio MS
J Biol Chem; 1985 Jan; 260(2):1243-7. PubMed ID: 2981838
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach.
Marvaldi J; Luis J; Muller JM; el Battari A; Fantini J; Martin JM; Abadie B; Tirard A; Pichon J
Peptides; 1986; 7 Suppl 1():137-45. PubMed ID: 3018691
[TBL] [Abstract][Full Text] [Related]
8. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
Couvineau A; Laburthe M
Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841
[TBL] [Abstract][Full Text] [Related]
9. Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29).
Luis J; Muller JM; Abadie B; Martin JM; Marvaldi J; Pichon J
Eur J Biochem; 1986 May; 156(3):631-6. PubMed ID: 3009188
[TBL] [Abstract][Full Text] [Related]
10. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
11. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium.
Couvineau A; Laburthe M
J Clin Endocrinol Metab; 1985 Jul; 61(1):50-5. PubMed ID: 2987295
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal.
Meunier AC; Voisin P; Van Camp G; Cenatiempo Y; Muller JM
Neuropeptides; 1991 May; 19(1):1-8. PubMed ID: 1653910
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
Laburthe M; Breant B; Rouyer-Fessard C
Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173
[TBL] [Abstract][Full Text] [Related]
14. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.
Omary MB; Kagnoff MF
Science; 1987 Dec; 238(4833):1578-81. PubMed ID: 2825352
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
16. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
18. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
Couvineau A; Gammeltoft S; Laburthe M
J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
[TBL] [Abstract][Full Text] [Related]
20. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
